FdaApplication

NDA 050672

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGLAXOSMITHKLINE
application_typeNDA
approval_date1994-06-30

Products (2)

ProductActive ingredientStrengthDosage form
CEFTINCEFUROXIME AXETILEQ 250MG BASE/5MLFOR SUSPENSION;ORAL
CEFTINCEFUROXIME AXETILEQ 125MG BASE/5MLFOR SUSPENSION;ORAL

2 products